all report title image
  • Published On : Feb 2022
  • Code : CMI4905
  • Industry : Medical Devices
  • Pages : 196
  • Formats :

Laparoscopic power morcellators are Class II medical devices that cut tissue into smaller pieces so that it can be removed through a small incision site during laparoscopic (minimally invasive) procedures. They are primarily used for procedures such as hysterectomy and myomectomy. These morcellators are used in surgeries for removing gallbladder, kidneys, liver, and spleen. These are majorly used in two operational procedures such as hysterectomy (the surgical removal of a woman's uterus), and myomectomy (the surgical removal of uterine fibroids), which are benign tumor growths in the uterus, are two other procedures. The increasing prevalence of uterus fibroid due to various causes such as cancer, polyps, endometriosis, fibroids, and adenomyosis, is projected to drive the growth of the laparoscopic power morcellators market.

Global Laparoscopic Power Morcellators Market - Impact of the Coronavirus (COVID-19) Pandemic

The COVID-19 pandemic is expected to hamper the growth of the global laparoscopic power morcellators market over the forecast period owing to the delaying of medical surgeries. For instance, on July 6, 2021, PLOS one, a scientific journal for science and medicine, has published study on the impact of the COVID-19 pandemic on waiting times for elective surgery patients. Where the study concluded that the health care service providers patients will have increased elective surgery waiting times by one-third due to the pandemic, however the elective surgery rate will increase by one-fifth after the pandemic. This shows a drop in the usage of laparoscopic power morcellators, which could have a negative impact on the market growth.

The global laparoscopic power morcellators market is estimated to be valued at US$ 102.1 Mn in 2021 and is expected to exhibit a CAGR of 5.3% over the forecast period (2021-2028).  

Figure 1: Global Laparoscopic Power Morcellators Market Share, (%), Analysis, By Application, 2021

Laparoscopic Power Morcellators  | Coherent Market Insights

Increasing prevalence of Uterine Leiomyomata (UL) in women is expected to drive the growth of the global laparoscopic power morcellators market over the forecast period.

Increasing prevalence of uterine fibroids in women; will in turn increase the adoption of laparoscopic power morcellators which is expected to drive the growth of the global laparoscopic power morcellators market over the forecast period. For instance, According to the article published in August 2021, the prevalence and burden of symptomatic uterine leiomyomata which is also called as fibroids and benign tumors of the uterus among women was approximately 1 in 20 or 5% or 13.6 million people globally.

Market players are indulged in following guidelines issued by regulatory authorities to receive 510 (k) clearance for the products such as laparoscopic power morcellators, which is expected to drive the growth of the global laparoscopic power morcellators market over the forecast period.

Companies are focused on developing new laparoscopic power morcellators with 510 (k) product clearance based on new regulatory guidelines from the regulatory authorities which is expected to drive the growth of the global laparoscopic power morcellators market over the forecast period. For instance, on February 3, 2021, Olympus America indicated that it supported the U.S. Food and Drug Administration (FDA) published guidance recommendations suggesting that laparoscopic power morcellators in gynecological procedures must be performed using an approved containment device. Olympus is now the sole manufacturer having a 510(k)-cleared containment laparoscopic power morcellation device in the U.S.

CMI table icon

Laparoscopic Power Morcellators Market Report Coverage

Report Coverage Details
Base Year: 2020 Market Size in 2021:

US$ 102.1 Mn

Historical Data for: 2018 to 2020 Forecast Period: 2021 to 2028
Forecast Period 2021 to 2028 CAGR: 5.3 % 2028 Value Projection:

US$ 153.5 Mn

Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Application: Hysterectomy, Myomectomy, Others
  • By End User: Hospitals and clinics, Surgical Centers 
Companies covered:

LiNA medical, Blue endo, Johnson and Johnson, Hangzhou kangji medical instruments, WISAP medical technology, Zhejiang geyi medical instrument, Karl storz GmbH, Medtronic, Richard wolf GmbH, Lumenis (Boston Scientific Corporation), Nouvag AG, RUDOLF Medical GmbH, and Olympus Corporation

Growth Drivers:
  • Increasing prevalence of Uterine Leiomyomata (UL) in women
  • Increasing product clearance by regulatory authorities 
Restraints & Challenges:
  • Product recall
  • Increased risk of cancer due to use of laparoscopic power morcellators

Global Laparoscopic Power Morcellators Market – Restraints

The product recall from the regulatory authorities is expected to hamper the growth of the global laparoscopic power morcellators market over the forecast period. For instance, on October 26, 2021, the U.S. Food and Drug Administration (US FDA) issued a recall notice for the PneumoLiner device which is intended for use as a tissue containment system during minimally invasive gynecologic laparoscopic surgery, manufactured by Olympus Corporation of the Americas has received recall notification from the U.S. Food and Drug Administration (FDA) due to manufacturing error.

Global Laparoscopic Power Morcellators Market – Regional Analysis

On the basis of region, the global laparoscopic power morcellators market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

Among regions, North America is expected to hold a dominant position during forecast period in laparoscopic power morcellators market, owing to the increasing prevalence of uterine cancer. For instance, in the U.S., 66,570 women are predicted to be diagnosed with uterine cancer, commonly known as endometrial cancer in 2021, according to the American Society of Clinical Oncology (ASCO). In the U.S., uterine cancer is the fourth most frequent cancer and sixth highest cause of mortality among women. As of 2021, there were over 600,000 uterine cancer survivors in the U.S. which thereby increases the demand for uterine cancer treatment. As a result of the rising prevalence of uterine cancer, demand for myomectomy and hysterectomy procedures is rising globally, which is expected to drive the growth of laparoscopic power morcellators market over the forecast period.

Figure 2: Global Laparoscopic Power Morcellators Market (US$ Mn), by Region, 2021

Laparoscopic Power Morcellators  | Coherent Market Insights

Global Laparoscopic Power Morcellators Market – Competitive Landscape

Major players operating in the global laparoscopic power morcellators market include LiNA medical, Blue endo, Johnson and Johnson, Endomedium, Hangzhou kangji medical instruments, WISAP medical technology, Zhejiang geyi medical instrument, Karl storz GmbH, Medtronic, Richard wolf GmbH, Lumenis (Boston Scientific Corporation), Nouvag AG, RUDOLF Medical GmbH, and Olympus Corporation.

A laparoscopic power morcellators is a surgical instrument used in less-invasive abdominal procedures such as laparoscopic hysterectomies and fibroid removal. Use of laparoscopic power morcellators allows for minimally invasive surgical procedures, which, when compared to open abdominal surgery, typically reduce the risk of infection and shorten the post-operative recovery period. However, when used in myomectomy or hysterectomy procedures, there is an increased risk of spreading unsuspected cancer and benign tissue within the abdomen and pelvis. The risk of unsuspected cancer increases with age, particularly in women over 50 years of age. The regulatory authorities have issued safety guidelines for laparoscopic power morcellators market players to be followed while developing devices so that it can minimize the further complications and enhance the research & development activities for upgradation of device.

Market Dynamics

Increasing prevalence of hysterectomy in women is expected to drive the growth of global laparoscopic power morcellators market. For instance, on January 30, 2021, Longitudinal Ageing Study in India (LASI) released data for percentage of women who had undergone hysterectomy among older adult women by in India during 2017-18 which indicates that 12.5% of women aged between 45 and 59, and 9.9% of women aged more than 60. Hence, such growing cases which require hysterectomy is likely to promote the adoption of laparoscopic power morcellators.

In addition, the increasing awareness by regulatory authorities for laparoscopic power morcellators is expected to increase the growth of the global laparoscopic power morcellators market over the forecast period. For instance, on December 29, 2020, the U.S. Food and Drug Administration (FDA) issued labeling guidelines for product to manufacturer of laparoscopic power morcellators to mention the warning on the box of morcellators about risk of cancer infection by using laparoscopic power morcellators which may spread the cancer or decrease the long term survival of patients. Hence, increasing the scope for market players to develop new devices of laparoscopic power morcellators to avoid the risk of cancer.

Key features of the study:

  • This report provides an in-depth analysis of global laparoscopic power morcellators market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2021-2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global laparoscopic power morcellators market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include LiNA Medical, Blue Endo, Johnson and Johnson, Hangzhou Kangji Medical Instruments, WISAP Medical Technology, Zhejiang Geyi Medical Instrument, Karl Storz GmbH, Medtronic, Richard Wolf GmbH, Lumenis (Boston Scientific Corporation), Nouvag AG, RUDOLF Medical GmbH, and Olympus Corporation
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The global laparoscopic power morcellators market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global laparoscopic power morcellators market

Detailed Segmentation:

  • Global Laparoscopic Power Morcellators Market, By Application:
    • Hysterectomy
    • Myomectomy
    • Others
  • Global Laparoscopic Power Morcellators Market, By End User:
    • Hospitals and clinics
    • Surgical Centers 
  • Global Laparoscopic Power Morcellators Market, By Region:
    • North America
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Country:
        • U.K.
        • Germany
        • Italy
        • Spain
        • France
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Country:
        • Australia
        • India
        • China
        • Japan
        • ASEAN
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • LiNA Medical*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Blue Endo
    • Johnson and Johnson
    • Hangzhou Kangji Medical Instruments
    • WISAP Medical Technology
    • Zhejiang Geyi Medical Instrument
    • Karl Storz GmbH
    • Medtronic
    • Richard Wolf GmbH
    • Lumenis (Boston Scientific Corporation)
    • Nouvag AG
    • RUDOLF Medical GmbH
    • Olympus Corporation

“*” marked represents similar segmentation in other categories in the respective section.

Frequently Asked Questions

The global laparoscopic power morcellators market is expected to exhibit a CAGR of 5.3% during the forecast period (2021-2028).
The market is estimated to be valued at US$ 102.1 Mn in 2021.
LiNA medical, Blue endo, Johnson and Johnson, Hangzhou kangji medical instruments, WISAP medical technology, Zhejiang geyi medical instrument, Karl storz GmbH, Medtronic, Richard wolf GmbH, Lumenis (Boston Scientific Corporation), Nouvag AG, RUDOLF Medical GmbH, and Olympus Corporation are some of the prominent players operating in the market over the forecast period.
The market is expected to be valued at US$ 153.5 Mn in 2028.
North America is the prominent region in the market.
Hysterectomy, which belongs to the application segment is the prominent segment in the market.

Related Reports

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo